[Skip to Content]
[Skip to Content Landing]
Medical News and Perspectives
June 8, 2005

TB Drug Research Picks Up the Pace

JAMA. 2005;293(22):2705-2707. doi:10.1001/jama.293.22.2705

As the current standard of care for tuberculosis (TB) is based on less-than-ideal drugs that were discovered over four decades ago, TB treatment could use a shot in the arm. And indeed, renewed interest in TB drug research across the board in the nonprofit, academic, and commercial realms is funneling promising candidates into the TB drug pipeline.

“A number of years ago, there was nothing on the horizon, and now everyone’s energized,” said Scott Franzblau, PhD, director of the Institute for Tuberculosis Research at the University of Illinois at Chicago.

First Page Preview View Large
First page PDF preview
First page PDF preview